ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · Real-Time Price · USD
1.800
+0.030 (1.69%)
At close: Jul 2, 2026, 4:00 PM EDT
1.740
-0.060 (-3.33%)
After-hours: Jul 2, 2026, 7:52 PM EDT
ABVC BioPharma Market Cap
ABVC BioPharma has a market cap or net worth of $45.49 million as of July 2, 2026. Its market cap has increased by 35.78% in one year.
Market Cap
45.49M
Enterprise Value
48.01M
1-Year Change
35.78%
Ranking
Category
Stock Price
$1.80
Market Cap Chart
Since August 3, 2021, ABVC BioPharma's market cap has decreased from $79.50M to $45.49M, a decrease of -42.79%. That is a compound annual growth rate of -10.74%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 46.80M | -9.65% |
| Dec 31, 2025 | 51.80M | 572.73% |
| Dec 31, 2024 | 7.70M | -8.33% |
| Dec 29, 2023 | 8.40M | -58.82% |
| Dec 30, 2022 | 20.40M | -78.97% |
| Dec 31, 2021 | 97.00M | 22.01% |
| Aug 3, 2021 | 79.50M | - |
View and export this data all the way back to 2021. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CervoMed | 49.91M |
| Eloxx Pharmaceuticals | 48.84M |
| PDS Biotechnology | 48.78M |
| Hyperion DeFi | 47.60M |
| Metagenomi Therapeutics | 45.55M |
| INmune Bio | 44.66M |
| Apollomics | 44.27M |
| Veraxa Biotech AG | 43.50M |